WAT
Waters Corp.

754
Mkt Cap
$61.18B
Volume
163.00
52W High
$414.15
52W Low
$275.05
PE Ratio
35.06
WAT Fundamentals
Price
$328.14
Prev Close
$381.29
Open
$332.29
50D MA
$389.25
Beta
1.01
Avg. Volume
500,015.40
EPS (Annual)
$10.71
P/B
9.74
Rev/Employee
$389,261.45
Loading...
Loading...
News
all
press releases
GUARDCAP ASSET MANAGEMENT Ltd Decreases Holdings in Waters Corporation $WAT
GUARDCAP ASSET MANAGEMENT Ltd lowered its holdings in Waters Corporation (NYSE:WAT - Free Report) by 9.1% during the third quarter, according to the company in its most recent filing with the SEC...
MarketBeat·4h ago
News Placeholder
More News
News Placeholder
Waters (NYSE:WAT) Shares Gap Down - Time to Sell?
Waters (NYSE:WAT) Shares Gap Down - Time to Sell...
MarketBeat·15h ago
News Placeholder
Waters Q4 Earnings Call Highlights
Waters (NYSE:WAT) executives said the company closed out 2025 with a strong finish and entered 2026 with a major portfolio expansion following the completion of its acquisition of Becton, Dickinson...
MarketBeat·20h ago
News Placeholder
Stock Market Today: Stocks mixed after Japan election shakes global markets
This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here.Happy Monday. This is TheStreet's Stock...
TheStreet.com·22h ago
News Placeholder
Waters (NYSE:WAT) Issues Q1 2026 Earnings Guidance
Waters (NYSE:WAT) updated its first quarter 2026 earnings guidance. The company provided EPS guidance of 2.250-2.350 for the period, compared to the consensus estimate of 2.520. The company also...
MarketBeat·22h ago
News Placeholder
Waters (NYSE:WAT) Updates FY 2026 Earnings Guidance
Waters (NYSE:WAT) updated its FY 2026 earnings guidance. The company provided EPS guidance of 14.300-14.500 for the period, compared to the consensus estimate of 14.290. The company also issued...
MarketBeat·23h ago
News Placeholder
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation PR...
PR Newswire·23h ago
News Placeholder
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses PR Newswire MILFORD, Mass...
PR Newswire·23h ago
News Placeholder
Waters (WAT) Beats Q4 Earnings and Revenue Estimates
Waters (WAT) delivered earnings and revenue surprises of +0.74% and +0.55%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·24h ago
News Placeholder
Waters (NYSE:WAT) Releases Earnings Results, Beats Estimates By $0.03 EPS
Waters (NYSE:WAT - Get Free Report) issued its earnings results on Monday. The medical instruments supplier reported $4.53 EPS for the quarter, beating the consensus estimate of $4.50 by $0.03. The...
MarketBeat·1d ago
<
1
2
...
>

Latest WAT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.